Related Experiment Videos
Motion automated perimetry identifies early glaucomatous field defects
C F Bosworth1, P A Sample, N Gupta
1Glaucoma Center and Department of Ophthalmology, University of California, San Diego, La Jolla 92093-0946, USA.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|September 25, 1998
Summary
Motion automated perimetry effectively identifies early glaucoma visual field defects in glaucoma and suspected glaucoma patients. Further refinement may enhance its diagnostic utility for ocular hypertension.
Area of Science:
- Ophthalmology
- Visual Neuroscience
- Medical Technology
Background:
- Glaucoma diagnosis relies on detecting progressive visual field defects.
- Early detection is crucial for preventing irreversible vision loss.
- Novel perimetric techniques are being explored to improve diagnostic sensitivity.
Purpose of the Study:
- To evaluate the efficacy of motion automated perimetry (MAP) in identifying early glaucomatous visual field defects.
- To compare MAP performance against standard visual field tests in various glaucoma-related patient groups.
Main Methods:
- MAP, including a foveally centered motion test, and standard visual field tests were administered to normal subjects, patients with suspected glaucoma, ocular hypertension, and primary open-angle glaucoma.
- Performance on motion tests was compared with standard perimetry results.
Main Results:
- Perimetric motion thresholds significantly differentiated patient groups (P<.001).
- MAP identified visual field defects in 90.5% of glaucoma, 39.3% of suspected glaucoma, and 27.8% of ocular hypertension patients.
- Motion thresholds correlated significantly with standard visual field thresholds (P<.001).
Conclusions:
- MAP demonstrates potential for detecting early glaucomatous visual field abnormalities, including in patients with suspected glaucoma and ocular hypertension.
- The study suggests that testing discrete locations may enhance MAP's diagnostic utility.
- MAP shows promise as an adjunctive tool in glaucoma screening and diagnosis.